Additional File 3 of the Fusiform Gyrus Exhibits an Epigenetic Signature for Alzheimer’s Disease

Dingailu Ma,Irfete S. Fetahu,Mei Wang,Rui Fang,Jiahui Li,Huan Liu,Tobin Gramyk,Isabella Iwanicki,Sophie Gu,Winnie Xu,Li Tan,Feizhen Wu,Yujiang G. Shi

DOI: https://doi.org/10.6084/m9.figshare.12885724

2020-01-01

Abstract:Additional file 3: Table S2. ST2_Top_DEG_in_heatmap_AD-risk-factor_TF.xlsx.

What problem does this paper attempt to address?

Additional File 8 of the Fusiform Gyrus Exhibits an Epigenetic Signature for Alzheimer’s Disease

Dingailu Ma,Irfete S. Fetahu,Mei Wang,Rui Fang,Jiahui Li,Huan Liu,Tobin Gramyk,Isabella Iwanicki,Sophie Gu,Winnie Xu,Li Tan,Feizhen Wu,Yujiang G. Shi

DOI: https://doi.org/10.6084/m9.figshare.12885739

2020-01-01

Abstract:Additional file 8: Table S7. ST7_validated_genes_function_annotation.xlsx.
The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease

Dingailu Ma,Irfete S. Fetahu,Mei Wang,Rui Fang,Jiahui Li,Hang Liu,Tobin Gramyk,Isabella Iwanicki,Sophie Gu,Winnie Xu,Li Tan,Feizhen Wu,Yujiang G. Shi

DOI: https://doi.org/10.1186/s13148-020-00916-3

2020-08-27

Clinical Epigenetics

Abstract:Abstract Background Alzheimer’s disease (AD) is the most common type of dementia, and patients with advanced AD frequently lose the ability to identify family members. The fusiform gyrus (FUS) of the brain is critical in facial recognition. However, AD etiology in the FUS of AD patients is poorly understood. New analytical strategies are needed to reveal the genetic and epigenetic basis of AD in FUS. Results A complex of new analytical paradigms that integrates an array of transcriptomes and methylomes of normal controls, AD patients, and “AD-in-dish” models were used to identify genetic and epigenetic signatures of AD in FUS. Here we identified changes in gene expression that are specific to the FUS in brains of AD patients. These changes are closely linked to key genes in the AD network. Profiling of the methylome (5mC/5hmC/5fC/5caC) at base resolution identified 5 signature genes ( COL2A1 , CAPN3 , COL14A1 , STAT5A , SPOCK3 ) that exhibit perturbed expression, specifically in the FUS and display altered DNA methylome profiles that are common across AD-associated brain regions. Moreover, we demonstrate proof-of-principle that AD-associated methylome changes in these genes effectively predict the disease prognosis with enhanced sensitivity compared to presently used clinical criteria. Conclusions This study identified a set of previously unexplored FUS-specific AD genes and their epigenetic characteristics, which may provide new insights into the molecular pathology of AD, attributing the genetic and epigenetic basis of FUS to AD development.

oncology,genetics & heredity
The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease

Dingailu Ma,Irfete S Fetahu,Mei Wang,Rui Fang,Jiahui Li,Hang Liu,Tobin Gramyk,Isabella Iwanicki,Sophie Gu,Winnie Xu,Li Tan,Feizhen Wu,Yujiang G Shi

DOI: https://doi.org/10.1186/s13148-020-00916-3

2020-08-27

Abstract:Background: Alzheimer's disease (AD) is the most common type of dementia, and patients with advanced AD frequently lose the ability to identify family members. The fusiform gyrus (FUS) of the brain is critical in facial recognition. However, AD etiology in the FUS of AD patients is poorly understood. New analytical strategies are needed to reveal the genetic and epigenetic basis of AD in FUS. Results: A complex of new analytical paradigms that integrates an array of transcriptomes and methylomes of normal controls, AD patients, and "AD-in-dish" models were used to identify genetic and epigenetic signatures of AD in FUS. Here we identified changes in gene expression that are specific to the FUS in brains of AD patients. These changes are closely linked to key genes in the AD network. Profiling of the methylome (5mC/5hmC/5fC/5caC) at base resolution identified 5 signature genes (COL2A1, CAPN3, COL14A1, STAT5A, SPOCK3) that exhibit perturbed expression, specifically in the FUS and display altered DNA methylome profiles that are common across AD-associated brain regions. Moreover, we demonstrate proof-of-principle that AD-associated methylome changes in these genes effectively predict the disease prognosis with enhanced sensitivity compared to presently used clinical criteria. Conclusions: This study identified a set of previously unexplored FUS-specific AD genes and their epigenetic characteristics, which may provide new insights into the molecular pathology of AD, attributing the genetic and epigenetic basis of FUS to AD development.
Additional File 2 of Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Yanan Chu,Fangcong Yu,Yakui Wu,Jing Yang,Jiaran Shi,Tianxin Ye,Deheng Han,Xingxiang Wang

DOI: https://doi.org/10.6084/m9.figshare.20236361

2022-01-01

Abstract:Additional file 2. DEGs involved in AF samples.
Additional File 4: of Integrated Biology Approach Reveals Molecular and Pathological Interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila Models

Michiko Sekiya,Minghui Wang,Naoki Fujisaki,Yasufumi Sakakibara,Xiuming Quan,Michelle E. Ehrlich,Philip De Jager,David A. Bennett,Eric E. Schadt,Sam Gandy,Kanae Ando,Bin Zhang,Koichi Iijima

DOI: https://doi.org/10.6084/m9.figshare.6067082

2018-01-01

Abstract:Table S3. Functional enrichment of DEGs identified in Aβ42, Aβ42/TREM2WT/TYROBP, and Aβ42/TREM2R47H/TYROBP files. (XLSX 23 kb)
Additional File 3: of Integrated Biology Approach Reveals Molecular and Pathological Interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila Models

Michiko Sekiya,Minghui Wang,Naoki Fujisaki,Yasufumi Sakakibara,Xiuming Quan,Michelle E. Ehrlich,Philip De Jager,David A. Bennett,Eric Schadt,Sam Gandy,Kanae Ando,Bin Zhang,Koichi Iijima

DOI: https://doi.org/10.6084/m9.figshare.6067073

2018-01-01

Abstract:Table S2. Functional enrichment of DEGs identified in TREM2WT/TYROBP, TREM2R47H/TYROBP, and Aß42 files. (XLSX 23 kb)
The YTHDF Proteins Shape the Brain Gene Signatures of Alzheimer's Disease

Shinya Tasaki,Denis R. Avey,Nicola A. Kearns,Artemis Iatrou,Chunjiang Yu,Sashini De Tissera,Himanshu Vyas,Jishu Xu,Daniel J. Flood,Katherine Rothamel,Aliza P. Wingo,Thomas S. Wingo,Nicholas T. Seyfried,Philip L. De Jager,Gene Yeo,Chris Gaiteri,David A Bennett,Yanling Wang

DOI: https://doi.org/10.1101/2024.10.23.619425

2024-10-23

Abstract:The gene signatures of Alzheimer's Disease (AD) brains reflect an output of a complex interplay of genetic, epigenetic, epi-transcriptomic, and post-transcriptional regulations. To identify the most significant factor that shapes the AD brain signature, we developed a machine learning model (DEcode-tree) to integrate cellular and molecular factors explaining differential gene expression in AD. Our model indicates that YTHDF proteins, the canonical readers of N6-methyladenosine RNA modification (m6A), are the most influential predictors of the AD brain signature. We then show that protein modules containing YTHDFs are downregulated in human AD brains, and knocking out YTHDFs in iPSC-derived neural cells recapitulates the AD brain gene signature in vitro. Furthermore, eCLIP-seq analysis revealed that YTHDF proteins influence AD signatures through both m6A-dependent and independent pathways. These results indicate the central role of YTHDF proteins in shaping the gene signature of AD brains.

Neuroscience
Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Chenming Liu,Xi Zhang,Huazhen Chai,Sutong Xu,Qiulu Liu,Yuping Luo,Siguang Li

DOI: https://doi.org/10.7150/ijms.66422

2022-01-01

Abstract:Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by cognitive impairment and memory loss, for which there is no effective cure to date. In the past several years, numerous studies have shown that increased inflammation in AD is a major cause of cognitive impairment. This study aimed to reveal 22 kinds of peripheral immune cell types and key genes associated with AD. The prefrontal cortex transcriptomic data from Gene Expression Omnibus (GEO) database were collected, and CIBERSORT was used to assess the composition of 22 kinds of immune cells in all samples. Weighted gene co-expression network analysis (WGCNA) was used to construct gene co-expression networks and identified candidate module genes associated with AD. The least absolute shrinkage and selection operator (LASSO) and random forest (RF) models were constructed to analyze candidate module genes, which were selected from the result of WGCNA. The results showed that the immune infiltration in the prefrontal cortex of AD patients was different from healthy samples. Of all 22 kinds of immune cells, M1 macrophages were the most relevant cell type to AD. We revealed 10 key genes associated with AD and M1 macrophages by LASSO and RF analysis, including ARMCX5, EDN3, GPR174, MRPL23, RAET1E, ROD1, TRAF1, WNT7B, OR4K2 and ZNF543. We verified these 10 genes by logistic regression and k-fold cross-validation. We also validated the key genes in an independent dataset, and found GPR174, TRAF1, ROD1, RAET1E, OR4K2, MRPL23, ARMCX5 and EDN3 were significantly different between the AD and healthy controls. Moreover, in the 5XFAD transgenic mice, the differential expression trends of Wnt7b, Gpr174, Ptbp3, Mrpl23, Armcx5 and Raet1e are consistent with them in independent dataset. Our results provided potential therapeutic targets for AD patients.
Spatially Resolved Transcriptomics Reveals Gene Signatures Underlying the Vulnerability of Human Middle Temporal Gyrus in Alzheimer's Disease

Shuo Chen,Yuzhou Chang,Liangping Li,Diana Acosta,Cody Morrison,Cankun Wang,Dominic Julian,Mark E. Hester,Geidy E. Serrano,Thomas G. Beach,Qin Ma,Hongjun Fu

DOI: https://doi.org/10.2139/ssrn.3898080

2021-01-01

SSRN Electronic Journal

Abstract:Human middle temporal gyrus (MTG) is a vulnerable brain region in early Alzheimer’s disease (AD); however, little is known about the molecular mechanisms underlying this regional vulnerability. Here we use the 10x Visium platform to define the spatial topography of gene expression in the MTG from both early AD and control cases. We identify differentially expressed genes (DEGs) and enriched pathways that may contribute to the layer-specific vulnerability of AD pathology. Also, gene co-expression analyses reveal four gene modules, which significantly change their co-expression patterns in the presence of variations of AD pathology. Furthermore, we validate the changes of key representative DEGs that are associated with AD pathology using single-molecule fluorescent in situ hybridization. In summary, we provide a rich resource for the spatial transcriptomic profile of the human MTG, which will contribute to our understanding of the complex architecture and AD pathology of this vulnerable brain region.
Epigenetic Signatures of Methylated DNA Cytosine in Alzheimer’s Disease

Irfete S. Fetahu,Dingailu Ma,Kimberlie Rabidou,Christian Argueta,Michael Smith,Hang Liu,Feizhen Wu,Yujiang G. Shi

DOI: https://doi.org/10.1126/sciadv.aaw2880

IF: 13.6

2019-01-01

Science Advances

Abstract:Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common untreatable form of dementia. Identifying molecular biomarkers that allow early detection remains a key challenge in the diagnosis, treatment, and prognostic evaluation of the disease. Here, we report a novel experimental and analytical model characterizing epigenetic alterations during AD onset and progression. We generated the first integrated base-resolution genome-wide maps of the distribution of 5-methyl-cytosine (5mC), 5-hydroxymethyl-cytosine (5hmC), and 5-formyl/carboxy-cytosine (5fC/caC) in normal and AD neurons. We identified 27 AD region-specific and 39 CpG site-specific epigenetic signatures that were independently validated across our familial and sporadic AD models, and in an independent clinical cohort. Thus, our work establishes a new model and strategy to study the epigenetic alterations underlying AD onset and progression and provides a set of highly reliable AD-specific epigenetic signatures that may have early diagnostic and prognostic implications.
The UFMylation pathway is impaired in Alzheimer's disease

Tingxiang Yan,Michael G. Heckman,Emily C. Craver,Chia-Chen Liu,Bailey D. Rawlinson,Xue Wang,Melissa E. Murray,Dennis W. Dickson,Nilufer Ertekin-Taner,Zhenkun Lou,Guojun Bu,Wolfdieter Springer,Fabienne C. Fiesel

DOI: https://doi.org/10.1101/2024.05.24.595755

2024-05-26

Abstract:Background: Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles made of hyperphosphorylated tau and senile plaques composed of beta-amyloid. These pathognomonic deposits have been implicated in the pathogenesis, although the molecular mechanisms and consequences remain undetermined. UFM1 is an important, but understudied ubiquitin-like protein that is covalently attached to substrates. This UFMylation has recently been identified as major modifier of tau aggregation upon seeding in experimental models. However, potential alterations of the UFM1 pathway in human AD brain have not been investigated yet. Methods: Here we used frontal and temporal cortex samples from individuals with or without AD to measure the protein levels of the UFMylation pathway in human brain. We used multivariable regression analyses followed by Bonferroni correction for multiple testing to analyze associations of the UFMylation pathway with neuropathological characteristics, primary biochemical measurements of tau and additional biochemical markers from the same cases. We further studied associations of the UFMylation cascade with cellular stress pathways using Spearman correlations with bulk RNAseq expression data and functionally validated these interactions using gene-edited neurons that were generated by CRISPR-Cas9. Results: Compared to controls, human AD brain had increased protein levels of UFM1. Our data further indicates that this increase mainly reflects conjugated UFM1 indicating hyperUFMylation in AD. UFMylation was strongly correlated with pathological tau in both AD-affected brain regions. In addition, we found that the levels of conjugated UFM1 were negatively correlated with soluble levels of the deUFMylation enzyme UFSP2. Functional analysis of UFM1 and/or UFSP2 knockout neurons revealed that the DNA damage response as well as the unfolded protein response are perturbed by changes in neuronal UFM1 signaling. Conclusions: There are marked changes in the UFMylation pathway in human AD brain. These changes are significantly associated with pathological tau, supporting the idea that the UFMylation cascade might indeed act as a modifier of tau pathology in human brain. Our study further nominates UFSP2 as an attractive target to reduce the hyperUFMylation observed in AD brain but also underscores the critical need to identify risks and benefits of manipulating the UFMylation pathway as potential therapeutic avenue for AD.

Neuroscience
Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.

Benjamin C. Reiner,R. Crist,W. Berrettini,A. Weller,Thomas N. Ferraro,G. Doyle

DOI: https://doi.org/10.3233/jad-220391

2022-10-01

Abstract:BACKGROUND 5XFAD humanized mutant mice and Trem2 knockout (T2KO) mice are two mouse models relevant to the study of Alzheimer's disease (AD)-related pathology. OBJECTIVE To determine hippocampal transcriptomic and polyadenylation site usage alterations caused by genetic mutations engineered in 5XFAD and T2KO mice. METHODS Employing a publicly available single-nucleus RNA sequencing dataset, we used Seurat and Sierra analytic programs to identify differentially expressed genes (DEGs) and differential transcript usage (DTU), respectively, in hippocampal cell types from each of the two mouse models. We analyzed cell type-specific DEGs further using Ingenuity Pathway Analysis (IPA). RESULTS We identified several DEGs in both neuronal and glial cell subtypes in comparisons of wild type (WT) versus 5XFAD and WT versus T2KO mice, including Ttr, Fth1, Pcsk1n, Malat1, Rpl37, Rtn1, Sepw1, Uba52, Mbp, Arl6ip5, Gm26917, Vwa1, and Pgrmc1. We also observed DTU in common between the two comparisons in neuronal and glial subtypes, specifically in the genes Prnp, Rbm4b, Pnisr, Opcml, Cpne7, Adgrb1, Gabarapl2, Ubb, Ndfip1, Car11, and Stmn4. IPA identified 3 statistically significant canonical pathways that appeared in multiple cell types and that overlapped between 5XFAD and T2KO comparisons to WT, including 'FXR/RXR Activation', 'LXR/RXR Activation', and 'Acute Phase Response Signaling'. CONCLUSION DEG, DTU, and IPA findings, derived from two different mouse models of AD, highlight the importance of energy imbalance and inflammatory processes in specific hippocampal cell types, including subtypes of neurons and glial cells, in the development of AD-related pathology. Additional studies are needed to further characterize these findings.

Medicine,Biology
Additional File 3 of High-resolution Transcriptomics Informs Glial Pathology in Human Temporal Lobe Epilepsy

Balagopal Pai,Jessica Tomé-García,Wan Sze Cheng,German Nudelman,Kristin G. Beaumont,Saadi Ghatan,Fedor Panov,Elodia Caballero,Kwadwo Sarpong,Lara Marcuse,Ji Yeoun Yoo,Yan Jiang,Anne Schaefer,Schahram Akbarian,Robert Sebra,Dalila Pinto,Elena Zaslavsky,Nadejda M. Tsankova

DOI: https://doi.org/10.6084/m9.figshare.21385846

2022-01-01

Abstract:Additional file 3: Table S2. Differential expression, TLE vs. TL, nuclear RNA-seq datasets for astrocyte, OPC, and neuronal FANS populations, with annotation of dysregulated genes unique to each cell type.
Exploring Potential Biomarkers Underlying the Pathogenesis of Alzheimer's Disease by Bioinformatics Gene Analysis.

Yichen Zhao,Guilin Meng,Yanxin Zhao,Xueyuan Liu,Minjie Zhang,Yuchen Zhou,Xiaoye Ma

2021-03-01

Annals of clinical and laboratory science

Abstract:Alzheimer's disease (AD) is a neurodegenerative disease caused by both genetic and environmental factors. This study aimed to explore the underlying molecular mechanism of AD by bioinformatic gene analysis. The gene expression profiles of GSE16759 and GSE28146 were downloaded, and co-differentially expressed genes (co-DEGs) were identified by R software. Subsequently, the data were analyzed using a combined bioinformatics approach and predicted the microRNAs (miRNAs) targeting the key gene using miRNA databases. Based on the results of these analyses, ADAMTS1, CITED2, and GABRA2 were identified as co-DEGs. They were all associated with learning disorders (inference Score: 103.22, 140.41, and 96.26, respectively) and memory disorders (inference Score: 102.77, 132.68, and 81.80, respectively). The hub-genes of ADAMTS1, CITED2, and GABRA2 may be associated with AD. Additionally, miR-548c- 3p is probably a common target for ADAMTS1, CITED2, and GABRA2.

Medicine,Computer Science,Biology
Gliovascular transcriptional perturbations in Alzheimer's disease reveal molecular mechanisms of blood brain barrier dysfunction

Özkan İş,Xue Wang,Joseph S. Reddy,Yuhao Min,Elanur Yilmaz,Prabesh Bhattarai,Tulsi Patel,Jeremiah Bergman,Zachary Quicksall,Michael G. Heckman,Frederick Q. Tutor-New,Birsen Can Demirdogen,Launia White,Shunsuke Koga,Vincent Krause,Yasuteru Inoue,Takahisa Kanekiyo,Mehmet Ilyas Cosacak,Nastasia Nelson,Annie J. Lee,Badri Vardarajan,Richard Mayeux,Naomi Kouri,Kaancan Deniz,Troy Carnwath,Stephanie R. Oatman,Laura J. Lewis-Tuffin,Thuy Nguyen,Minerva M. Carrasquillo,Jonathan Graff-Radford,Ronald C. Petersen,Clifford R. Jr Jack,Kejal Kantarci,Melissa E. Murray,Kwangsik Nho,Andrew J. Saykin,Dennis W. Dickson,Caghan Kizil,Mariet Allen,Nilüfer Ertekin-Taner,for the Alzheimer's Disease Neuroimaging Initiative

DOI: https://doi.org/10.1038/s41467-024-48926-6

IF: 16.6

2024-06-22

Nature Communications

Abstract:To uncover molecular changes underlying blood-brain-barrier dysfunction in Alzheimer's disease, we performed single nucleus RNA sequencing in 24 Alzheimer's disease and control brains and focused on vascular and astrocyte clusters as main cell types of blood-brain-barrier gliovascular-unit. The majority of the vascular transcriptional changes were in pericytes. Of the vascular molecular targets predicted to interact with astrocytic ligands, SMAD3 , upregulated in Alzheimer's disease pericytes, has the highest number of ligands including VEGFA , downregulated in Alzheimer's disease astrocytes. We validated these findings with external datasets comprising 4,730 pericyte and 150,664 astrocyte nuclei. Blood SMAD3 levels are associated with Alzheimer's disease-related neuroimaging outcomes. We determined inverse relationships between pericytic SMAD3 and astrocytic VEGFA in human iPSC and zebrafish models. Here, we detect vast transcriptome changes in Alzheimer's disease at the gliovascular-unit, prioritize perturbed pericytic SMAD3 -astrocytic VEGFA interactions, and validate these in cross-species models to provide a molecular mechanism of blood-brain-barrier disintegrity in Alzheimer's disease.

multidisciplinary sciences
Single-cell multiregion dissection of Alzheimer's disease

Hansruedi Mathys,Carles A. Boix,Leyla Anne Akay,Ziting Xia,Jose Davila-Velderrain,Ayesha P. Ng,Xueqiao Jiang,Ghada Abdelhady,Kyriaki Galani,Julio Mantero,Neil Band,Benjamin T. James,Sudhagar Babu,Fabiola Galiana-Melendez,Kate Louderback,Dmitry Prokopenko,Rudolph E. Tanzi,David A. Bennett,Li-Huei Tsai,Manolis Kellis

DOI: https://doi.org/10.1038/s41586-024-07606-7

IF: 64.8

2024-07-25

Nature

Abstract:Alzheimer's disease is the leading cause of dementia worldwide, but the cellular pathways that underlie its pathological progression across brain regions remain poorly understood 1,2,3 . Here we report a single-cell transcriptomic atlas of six different brain regions in the aged human brain, covering 1.3 million cells from 283 post-mortem human brain samples across 48 individuals with and without Alzheimer's disease. We identify 76 cell types, including region-specific subtypes of astrocytes and excitatory neurons and an inhibitory interneuron population unique to the thalamus and distinct from canonical inhibitory subclasses. We identify vulnerable populations of excitatory and inhibitory neurons that are depleted in specific brain regions in Alzheimer's disease, and provide evidence that the Reelin signalling pathway is involved in modulating the vulnerability of these neurons. We develop a scalable method for discovering gene modules, which we use to identify cell-type-specific and region-specific modules that are altered in Alzheimer's disease and to annotate transcriptomic differences associated with diverse pathological variables. We identify an astrocyte program that is associated with cognitive resilience to Alzheimer's disease pathology, tying choline metabolism and polyamine biosynthesis in astrocytes to preserved cognitive function late in life. Together, our study develops a regional atlas of the ageing human brain and provides insights into cellular vulnerability, response and resilience to Alzheimer's disease pathology.

multidisciplinary sciences
IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis

Rong He,Jishuai Cheng,Yue Qiu,Yiwen Hu,Jia Liu,Ting-Hua Wang,Xue Cao

DOI: https://doi.org/10.1016/j.exger.2024.112512

Abstract:Objective: This study investigated sex-specific pathogenesis mechanisms in Alzheimer's disease (AD) using single-nucleus RNA sequencing (snRNA-seq) data. Methods: Data from the Gene Expression Omnibus (GEO) were searched using terms "Alzheimer's Disease", "single cell", and "Homo sapiens". Studies excluding APOE E4 and including comprehensive gender information with 10× sequencing methods were selected, resulting in GSE157827 and GSE174367 datasets from human prefrontal cortex samples. Sex-stratified analyses were conducted on these datasets, and the outcomes of the analysis for GSE157827 were compared with those of GSE174367. The findings were validated using expression profiling from the mouse dataset GSE85162. Furthermore, real-time PCR experiments in mice further confirmed these findings. The Seurat R package was used to identify cell types, and batch effects were mitigated using the Harmony R package. Cell proportions by sex were compared using the Mann-Whitney-Wilcoxon test, and gene expression variability was displayed with an empirical cumulative distribution plot. Differentially expressed genes were identified using the FindMarkers function with the MAST test. Transcription factors were analyzed using the RcisTarget R package. Results: Seven cell types were identified: astrocytes, endothelial cells, excitatory neurons, inhibitory neurons, microglia, oligodendrocytes, and oligodendrocyte progenitor cells. Additionally, five distinct subpopulations of both endothelial and microglial cells were also identified, respectively. Key findings included: (1) In endothelial cells, genes involved in synapse organization, such as Insulin Like Growth Factor 1 Receptor (IGF1R) and Fms Related Receptor Tyrosine Kinase 1(FLT1), showed higher expression in females with AD. (2) In microglial cells, genes in the ribosome pathway exhibited higher expression in males without AD compared to females (with or without AD) and males with AD. (3) Chromodomain Helicase DNA Binding Protein 2 (CHD2) negatively regulated gene expression in the ribosome pathway in male microglia, suppressing AD, this finding was further validated in mice. (4) Differences between Asians and Caucasians were observed based on sex and disease status stratification. Conclusions: IGF1R and FLT1 in endothelial cells contribute to AD in females, while CHD2 negatively regulates ribosome pathway gene expression in male microglia, suppressing AD in humans and mice.
Single-cell Spatial Transcriptomics Analysis of Alzheimer's Disease Pathogenesis in Mouse Models

Xiangmin Xu,,

DOI: https://doi.org/10.59566/iabs.2023.p016

2023-12-15

Abstract:Understanding molecular mechanisms of Alzheimer’s disease (AD) has proven challenging as disease effects occur at multiple scales in different brain regions. We apply multiplexed error-robust fluorescence in situ hybridization (MERFISH) to generate spatially resolved single-cell RNA atlases from multiple cortical and subcortical brain regions in 5xFAD and age-matched C57 wild-type mice. We also investigate the effect of the TREM2R47H mutation, a strong risk factor for the development of AD in humans, producing similar atlases for Trem2R47H and Trem2R47H-5xFAD mice. We identify amyloid- beta plaque proximal molecular alterations in microglia and astrocytes, but also in five neuronal cell types. Spatial analysis of microglia and astrocyte concentrations reveals Trem2R47H -dependent regional variations, as well as regional transcriptional variation independent of either 5xFAD or Trem2R47H mutations. Cortical excitatory neurons exhibit a consistent Trem2R47H -induced expression increase in Ntrk2, and other MAPK signaling- associated genes, and thalamic excitatory neurons exhibit both 5xFAD and Trem2R47H induced gene program alterations. Additionally, nearly every neuronal cell type exhibits subclusters with decreased 5xFAD populations. Taken together, our MERFISH analysis of 5xFAD and Trem2R47H Alzheimer’s mouse models reveals spatially localized, cell-type-specific, plaque and Trem2R47H induced transcriptome dysregulations in cortical and subcortical brain regions.
Identification and immunological characterization of genes associated with ferroptosis in Alzheimer's disease and experimental demonstration

Zhen Xiao,Rui Hu,Wan-Lu Liu,Xiao-Xuan He,Ming-You Dong,Zhong-Shi Huang

DOI: https://doi.org/10.3892/mmr.2024.13279

Abstract:The incidence of Alzheimer's disease (AD) is rising globally, yet its treatment and prediction of this condition remain challenging due to the complex pathophysiological mechanisms associated with it. Consequently, the objective of the present study was to analyze and characterize the molecular mechanisms underlying ferroptosis‑related genes (FEGs) in the pathogenesis of AD, as well as to construct a prognostic model. The findings will provide new insights for the future diagnosis and treatment of AD. First, the AD dataset GSE33000 from the Gene Expression Omnibus database and the FEGs from FerrDB were obtained. Next, unsupervised cluster analysis was used to obtain the FEGs that were most relevant to AD. Subsequently, enrichment analyses were performed on the FEGs to explore biological functions. Subsequently, the role of these genes in the immune microenvironment was elucidated through CIBERSORT. Then, the optimal machine learning was selected by comparing the performance of different machine learning models. To validate the prediction efficiency, the models were validated using nomograms, calibration curves, decision curve analysis and external datasets. Furthermore, the expression of FEGs between different groups was verified using reverse transcription quantitative PCR and western blot analysis. In AD, alterations in the expression of FEGs affect the aggregation and infiltration of certain immune cells. This indicated that the occurrence of AD is strongly associated with immune infiltration. Finally, the most appropriate machine learning models were selected, and AD diagnostic models and nomograms were built. The present study provided novel insights that enhance understanding with regard to the molecular mechanism of action of FEGs in AD. Moreover, the present study provided biomarkers that may facilitate the diagnosis of AD.
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers

Sneh Prabha,Mohd Sajad,Farah Anjum,Md Imtaiyaz Hassan,Anas Shamsi,Sonu Chand Thakur

DOI: https://doi.org/10.1177/13872877241297335

2024-11-29

Journal of Alzheimer s Disease

Abstract:Background Alzheimer's disease (AD) is an advancing neurodegenerative disorder distinguished by the formation of amyloid plaques and neurofibrillary tangles in the human brain. Nevertheless, the lack of peripheral biomarkers that can detect the development of AD remains a significant limitation. Objective The main aim of this work was to discover the molecular markers associated with AD. Methods We conducted a comprehensive microarray analysis of gene expression data from hippocampus tissue in AD patients and control samples using three microarray datasets (GSE1297, GSE28146, and GSE29378) collected from Gene Expression Omnibus (GEO). The datasets were pre-processed and normalized, revealing 346 significant genes, 103 of which were upregulated and 243 downregulated. The PPI network of significant genes was constructed to detect the top 50 hub genes, which were then further analyzed using Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes and Genomes pathway (KEGG), and GSEA, revealing 47 key genes involved in AD-related pathways. These key genes were then subjected to feed forward loop (FFL) motif analysis for the prediction of transcriptional factors (TFs) and microRNAs (miRNAs) mediated gene regulatory networks. Results The interaction of AD-associated TFs HNF4A, SPI1, EGR1, STAT3, and MYC and miRNAs hsa-miR-155-5p and hsa-miR-16-5p in the transcriptional and post-transcriptional events of 3 upregulated and 10 downregulated genes: H2AFZ, MCM3, MYO1C, AXIN1, CCND1, ETS2, MYH9, RELA, RHEB, SOCS3, TBL1X, TBP, TXNIP, and YWHAZ, respectively, has been identified. The miRNA/TF-mediated three types of the FFL motifs, i.e., miRNA-FFL, TF-FFL, and composite-FFL, were constructed, and seven common genes among these FFL were identified: CCND1, MYH9, SOCS3, RHEB, MYO1C, TXNIP, AXIN1, and TXNIP. Conclusions These findings may provide insights into the development of potential molecular markers for therapeutic management of AD.

neurosciences

Additional File 3 of the Fusiform Gyrus Exhibits an Epigenetic Signature for Alzheimer’s Disease

Additional File 8 of the Fusiform Gyrus Exhibits an Epigenetic Signature for Alzheimer’s Disease

The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease

The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease

Additional File 2 of Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Additional File 4: of Integrated Biology Approach Reveals Molecular and Pathological Interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila Models

Additional File 3: of Integrated Biology Approach Reveals Molecular and Pathological Interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila Models

The YTHDF Proteins Shape the Brain Gene Signatures of Alzheimer's Disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Spatially Resolved Transcriptomics Reveals Gene Signatures Underlying the Vulnerability of Human Middle Temporal Gyrus in Alzheimer's Disease

Epigenetic Signatures of Methylated DNA Cytosine in Alzheimer’s Disease

The UFMylation pathway is impaired in Alzheimer's disease

Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.

Additional File 3 of High-resolution Transcriptomics Informs Glial Pathology in Human Temporal Lobe Epilepsy

Exploring Potential Biomarkers Underlying the Pathogenesis of Alzheimer's Disease by Bioinformatics Gene Analysis.

Gliovascular transcriptional perturbations in Alzheimer's disease reveal molecular mechanisms of blood brain barrier dysfunction

Single-cell multiregion dissection of Alzheimer's disease

IGF1R and FLT1 in female endothelial cells and CHD2 in male microglia play important roles in Alzheimer's disease based on gender difference analysis

Single-cell Spatial Transcriptomics Analysis of Alzheimer's Disease Pathogenesis in Mouse Models

Identification and immunological characterization of genes associated with ferroptosis in Alzheimer's disease and experimental demonstration

Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers